Transitions between variant forms of primary biliary cirrhosis during long-term follow-up

European Journal of Internal Medicine

Volumn 20, Issue 4, 2009, Pages 398-402

  Lindgren, Stefan ^a   Glaumann, Hans ^b   Almer, Sven ^c   Bergquist, Annika ^b   Björnsson, Einar ^d   Broomé, Ulrika ^b   Danielsson, Åke ^e   Lebrun, Barbro ^b,f   Prytz, Hanne ^a   Olsson, Rolf ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f DANDERYD HOSPITAL   (Sweden)

Author keywords

Autoimmune cholangitis; Autoimmune hepatitis; Immunosuppression; Overlap syndrome; Primary biliary cirrhosis; Variant forms

Indexed keywords

AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; URSODEOXYCHOLIC ACID;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIMARY BILIARY CIRRHOSIS; SCORING SYSTEM; TREATMENT RESPONSE;

EID: 67349139257     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.12.011     Document Type: Article

References (24)

1. Metcalf J.V., Mitchison H.C., Palmer J.M., Jones D.E., Bassendine M.F., and James O.F. Natural history of early primary biliary cirrhosis. Lancet 348 (1996) 1399-1402
2. Oertelt S., Rieger R., Selmi C., Invernizzi P., Ansari A.A., Coppel R.L., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45 (2007) 659-665
3. Invernizzi P., Crosignani A., Battezzati P.M., Covini G., De Valle G., Larghi A., et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology 25 (1997) 1090-1095
4. Kim W.R., Poterucha J.J., Jorgensen R.A., Batts K.P., Homburger H.A., Dickson E.R., et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 26 (1997) 22-26
5. Michieletti P., Wanless I.R., Katz A., Scheuer P.J., Yeaman S.J.., Bassendine M.F., et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 35 (1994) 260-265
6. Lacerda M.A., Ludwig J., Dickson E.R., Jorgensen R.A., and Lindor K.D. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 90 (1995) 247-249
7. Goodman Z.D., McNally P.R., Davis D.R., and Ishak K.G. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 40 (1995) 1232-1242
8. Ben-Ari Z., Dhillon A.P., and Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 18 (1993) 10-15
9. Chou M.J., Lee S.L., Chen T.Y., and Tsay G.J. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis 54 (1995) 148-151
10. Gordon S.C., Quattrociocchi-Longe T.M., Khan B.A., Kodali V.P., Chen J., Silverman A.L., et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 108 (1995) 1802-1809
11. Gossard A.A., and Lindor K.D. Development of autoimmune hepatitis in primary biliary cirrhosis. Liver Int. 27 (2007) 1086-1090
12. Chazouillères O., Wendum D., Serfaty L., Montembault S., Rosmorduc O., and Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28 (1998) 296-301
13. Horsmans Y., Piret A., Brenard R., Rahier J., and Geubel A.P. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report. J Hepatol 21 (1994) 194-198
14. Alvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31 (1999) 929-938
15. Batts K.P., and Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (1995) 1409-1417
16. Poupon R. Autoimmune overlapping syndromes. Clin Liver Dis 7 (2003) 865-878
17. Olsson R, Lindgren S, Glaumann H, Almer S, Broomé U, Lebrun B, et al. High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis. Eur J Int Med 2009, in press.
18. Woodward J., and Neuberger J. Autoimmune overlap syndromes. Hepatology 33 (2001) 994-1002
19. Czaja A.J., Muratori P., Muratori L., Carpenter H.A., and Bianchi F.B. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 24 (2004) 322-329
20. Papamichalis P.A., Zachou K., Koukoulis G.K., Veloni A., Karacosta E.G., Kypri L., et al. The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders. J Autoimmune Dis 4 (2007) 3
21. Chazouillères O., Wendum D., Serfaty L., Rosmorduc O., and Poupon R. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 44 (2006) 400-406
22. Poupon R., Chazouilleres O., Corpechot C., and Chrétien Y. Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis. Hepatology 44 (2006) 85-90
23. Silveira M.G., Talwalkar J.A., Angulo P., and Lindor K.D. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102 (2007) 1244-1250
24. Lööf L., Adami H.O., Sparén P., Danielsson A., Eriksson L.S., Hultcrantz R., et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 20 (1994) 101-104